resmetirom
Marketedupdated 2mo agoby $MDGL MADRIGAL PHARMACEUTICALS, INC.
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for non-alcoholic fatty liver disease and cirrhosis of liver and 5 investigational indications.
all catalysts(4)
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that